Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-18 to 2024-03-19
Current total value of award: $1796.29
Description: 4563999784!QUILLIVANT XR ORAL SUSP 150ML 5MG/ML